+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Immunohistochemical Detection of P-glycoprotein in Breast Cancer and Its Significance as a Prognostic Factor



Immunohistochemical Detection of P-glycoprotein in Breast Cancer and Its Significance as a Prognostic Factor



Breast Cancer 4(4): 259-263



Overexpression of P-glycoprotein (Pgp) in tumors is one of the major mechanisms which mediates the multidrug resistance (MDR) phenotype. To evaluate the prognostic significance of Pgp in breast cancer, Pgp expression was examined in paraffin-embedded tissue sections of 94 breast cancer specimens by immunohistochemistry. Tissue specimens were obtained by mastectomy without preoperative chemotherapy. UIC2 monoclonal antibody which recognizes an extracellular epitope of human Pgp was employed. Of the 94 breast cancer specimens, 35(37.2%)were positive for Pgp expression. Pgp expression had no correlation with menopausal or hormone receptor status, axillary Iymph node involvement or tumor size. However, a significant correlation was observed between Pgp expression and disease relapse (p=0.0322). Pgp-positive patients showed a significantly shorter disease-free survival period than Pgp-negative patients by the Kaplan-Meier method (p=0.0433). These results suggest that immunohistochemical detection of Pgp in breast cancer tissue may have prognostic value after radical operation.

(PDF emailed within 1 workday: $29.90)

Accession: 046333471

Download citation: RISBibTeXText

PMID: 11091611


Related references

Immunohistochemical Detection of p53 and c-erbB-2 Proteins: Prognostic Significance in Operable Breast Cancer. Breast Cancer P(P): 17-23, 1994

Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma. Journal of the Society for Gynecologic Investigation 2(4): 653-659, 1995

Prognostic factors in breast cancer immunohistochemical staining for epidermal growth factor receptor pregnancy specific glycoprotein sp 1 and ncrc 11. Journal of Pathology 149(3): 234A, 1986

Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer. Hormones & Cancer 1(1): 21-33, 2011

Epidermal growth factor receptor-immunohistochemical detection and clinical significance for treatment of primary breast cancer. Anticancer Research 17(4a): 2799-2802, 1997

Immunohistochemical detection and prognostic significance of p53 in the primary tumor of breast carcinoma patients. Geburtshilfe und Frauenheilkunde 55(5): 252-257, 1995

Prognostic significance of glycoprotein pMQ1 in breast cancer. British Journal of Surgery 93(3): 309-314, 2006

The expression and prognostic significance of P-Glycoprotein in primary breast cancer. Zhongguo Zhongliu Linchuang 28(5): 325-328, May 20, 2001

The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy. Yonsei Medical Journal 33(2): 137-142, 1992

The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy. International Journal of Oncology 5(SUPPL ): 371, 1994

Value of immunohistochemical detection of p glycoprotein in breast cancer before and after induction chemotherapy. Proceedings of the American Association for Cancer Research Annual Meeting 32: 182, 1991

PCNA/cyclin and P-glycoprotein as prognostic factors in locally advanced breast cancer. An immunohistochemical, retrospective study. Tumori 79(3): 214-218, 1993

Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer. Cancer (Philadelphia) 71(9): 2756-2763, 1993

Immunohistochemical expression and prognostic significance of HIF-1α and VEGF-C in neuroendocrine breast cancer. Anticancer Research 32(12): 5227-5232, 2013